BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37814565)

  • 41. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.
    Youngster I; Mahabamunuge J; Systrom HK; Sauk J; Khalili H; Levin J; Kaplan JL; Hohmann EL
    BMC Med; 2016 Sep; 14(1):134. PubMed ID: 27609178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?
    Tang G; Yin W; Liu W
    Diagn Microbiol Infect Dis; 2017 Aug; 88(4):322-329. PubMed ID: 28602517
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fecal Microbiota Transplantation Is Safe for Clostridiodies difficile Infection in Patients with Solid Tumors Undergoing Chemotherapy.
    Mendelsohn RB; Kaltsas A; King S; Hwang C; Kassam Z; Abend AM; Kramer E; Kamboj M
    Dig Dis Sci; 2022 Jun; 67(6):2503-2509. PubMed ID: 34089134
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alteration of gut microbial composition associated with the therapeutic efficacy of fecal microbiota transplantation in Clostridium difficile infection.
    Lee PC; Chang TE; Wang YP; Lee KC; Lin YT; Chiou JJ; Huang CW; Yang UC; Li FY; Huang HC; Wu CY; Huang YH; Hou MC
    J Formos Med Assoc; 2022 Sep; 121(9):1636-1646. PubMed ID: 34836663
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complete Microbiota Engraftment Is Not Essential for Recovery from Recurrent Clostridium difficile Infection following Fecal Microbiota Transplantation.
    Staley C; Kelly CR; Brandt LJ; Khoruts A; Sadowsky MJ
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results of the implementation of a multidisciplinary programme of faecal microbiota transplantation by colonoscopy for the treatment of recurrent Clostridium difficile infection.
    López-Sanromán A; Rodríguez de Santiago E; Cobo Reinoso J; Del Campo Moreno R; Foruny Olcina JR; García Fernández S; García García de Paredes A; Aguilera Castro L; Ferre Aracil C; Albillos Martínez A
    Gastroenterol Hepatol; 2017 Nov; 40(9):605-614. PubMed ID: 28433406
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fecal Microbiota Transplantation Is Safe and Effective in Patients With Clostridioides difficile Infection and Cirrhosis.
    Cheng YW; Alhaffar D; Saha S; Khanna S; Bohm M; Phelps E; Ghabril M; Orman E; Sashidhar S; Rogers N; Xu H; Khoruts A; Vaughn B; Kao D; Wong K; Cammarota G; Ianiro G; Dhere T; Kraft CS; Mehta N; Woodworth MH; Allegretti JR; Nativ L; Marcus J; El-Nachef N; Fischer M
    Clin Gastroenterol Hepatol; 2021 Aug; 19(8):1627-1634. PubMed ID: 32645451
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Faecal microbiota transplantation for recurrent C. difficile infections: challenges and improvement opportunities for clinical practice and healthcare systems.
    Hocking L; Ianiro G; Leong RW; Iqbal T; Kao D; Cabling M; Stockwell S; Romanelli RJ; Marjanovic S
    Aliment Pharmacol Ther; 2023 Mar; 57(5):549-564. PubMed ID: 36495561
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fecal microbiota transplantation for recurrent Clostridioides difficile infection in frail and very old patients.
    Montalto M; Gallo A; Agnitelli MC; Pellegrino S; Lipari A; Pero E; Covino M; Landi F; Gasbarrini A; Cammarota G; Ianiro G
    J Am Geriatr Soc; 2023 Nov; 71(11):3530-3537. PubMed ID: 37458581
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Donor, patient age and exposure to antibiotics are associated with the outcome of faecal microbiota transplantation for recurrent Clostridioides difficile infection: A prospective cohort study.
    Baunwall SMD; Hansen MM; Andreasen SE; Eriksen MK; Rågård N; Kelsen J; Grosen AK; Mikkelsen S; Erikstrup C; Dahlerup JF; Hvas CL
    Aliment Pharmacol Ther; 2023 Sep; 58(5):503-515. PubMed ID: 37482926
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fecal Microbiota Transplantation and Microbial Therapeutics for the Treatment of Clostridioides difficile Infection in Pediatric Patients.
    Bernard R; Hourigan SK; Nicholson MR
    J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S58-S63. PubMed ID: 34791396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Faecal Microbiota Transplantation is a simple, effective and safe treatment in the management of C. difficile infection in daily clinical practice.
    Ferre Aracil C; El Hajra Martínez I; Vera Mendoza MS; Ramos Martínez A; Muñez Rubio E; Fernández-Cruz A; Matallana Royo V; García-Maseda S; Sánchez Romero I; Martínez Ruiz R; Calleja Panero JL
    Enferm Infecc Microbiol Clin (Engl Ed); 2023 Apr; 41(4):206-210. PubMed ID: 36681571
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delivery of Fecal Material to Terminal Ileum Is Associated with Long-Term Success of Fecal Microbiota Transplantation.
    Weingarden AR; Treiger O; Ulsh L; Limketkai B; Goldenberg D; Okafor P; Sonu I; Stollman N; Neshatian L
    Dig Dis Sci; 2023 May; 68(5):2006-2014. PubMed ID: 36372864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An overview of
    Miguel A
    Br J Nurs; 2023 Jun; 32(12):546-549. PubMed ID: 37344135
    [No Abstract]   [Full Text] [Related]  

  • 56. [Fecal microbiota transplantation through colonoscopy for Clostridium difficile recurrent infection. Report of eight cases].
    Quera R; Ibáñez P; Simian D; Rivera D; Acuña G; Espinoza R
    Rev Med Chil; 2018 Aug; 146(8):823-830. PubMed ID: 30534859
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Superiority of Higher-Volume Fresh Feces Compared to Lower-Volume Frozen Feces in Fecal Microbiota Transplantation for Recurrent Clostridioides Difficile Colitis.
    Agarwal A; Maheshwari A; Verma S; Arrup D; Phillips L; Vinayek R; Nair P; Hagan M; Dutta S
    Dig Dis Sci; 2021 Jun; 66(6):2000-2004. PubMed ID: 32656604
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
    Tan X; Johnson S
    Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammatory Bowel Disease Affects the Outcome of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Khoruts A; Rank KM; Newman KM; Viskocil K; Vaughn BP; Hamilton MJ; Sadowsky MJ
    Clin Gastroenterol Hepatol; 2016 Oct; 14(10):1433-8. PubMed ID: 26905904
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fecal Microbiota Transplantation for Clostridioides difficile in High-Risk Older Adults Is Associated with Early Recurrence.
    Luo Y; Tixier EN; Grinspan AM
    Dig Dis Sci; 2020 Dec; 65(12):3647-3651. PubMed ID: 32078714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.